Abstract
1. Hydroxyethyl starch (HES) of molecular weight 450,000 has been extensively investigated as a plasma volume expander and HES of molecular weight 60,000 has been proposed for use as a cryoprotective agent in the freezing for preservation of red blood cells. In these applications considerable amounts of HES may be injected intravenously and it is therefore desirable to understand its behaviour in vivo.
2. After intravenous injection into rabbits, plasma levels of HES and clinical dextrans were determined using anthrone. HES persisted longer in the circulation than did the dextrans.
3. HES was recovered from the bloodstream of rabbits and shown by gel filtration to be of a narrower molecular size distribution than the injected material. Smaller molecules were removed, presumably by filtration at the glomerulus. Larger molecules may have been removed by cells of the reticuloendothelial system or possibly through the action of amylase.
4. The amylase in saliva was shown to break down HES into molecules of intermediate size with very little production of maltose units.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ballinger W. F., 2nd, Murray G. F., Morse E. E. Preliminary report on the use of hydroxyethyl starch solution in man. J Surg Res. 1966 Apr;6(4):180–183. doi: 10.1016/s0022-4804(66)80014-8. [DOI] [PubMed] [Google Scholar]
- DAVIES J. W., RICKETTS C. R., WILLIAMS B. N. PLASMA VOLUME EXPANSION BY RAPID INFUSION OF A LOW MOLECULAR WEIGHT DEXTRAN. Br J Pharmacol Chemother. 1963 Oct;21:220–225. doi: 10.1111/j.1476-5381.1963.tb01519.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrant J. Is there a common mechanism of protection of living cells by polyvinylpyrrolidone and glycerol ding freezing? Nature. 1969 Jun 21;222(5199):1175–1176. doi: 10.1038/2221175a0. [DOI] [PubMed] [Google Scholar]
- Gollub S., Schechter D. C., Hirose T., Bailey C. P. Use of hydroxyethyl starch solution in extensive surgical operations. Surg Gynecol Obstet. 1969 Apr;128(4):725–728. [PubMed] [Google Scholar]
- Knorpp C. T., Merchant W. R., Gikas P. W., Spencer H. H., Thompson N. W. Hydroxyethyl starch: extracellular cryophylactic agent for erythrocytes. Science. 1967 Sep 15;157(3794):1312–1313. doi: 10.1126/science.157.3794.1312. [DOI] [PubMed] [Google Scholar]
- Lee W. H., Jr, Cooper N., Weidner M. G., Jr, Murner E. S. Clinical evaluation of a new plasma expander hydroxyethyl starch. J Trauma. 1968 May;8(3):381–393. doi: 10.1097/00005373-196805000-00005. [DOI] [PubMed] [Google Scholar]
- Ricketts C. R. Molecular composition of transfusion dextran. A report to the Medical Research Council's Blood Transfusion Research Committee. Br Med J. 1966 Dec 10;2(5527):1423–1426. doi: 10.1136/bmj.2.5527.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Solanke T. F. Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander). Br Med J. 1968 Sep 28;3(5621):783–785. doi: 10.1136/bmj.3.5621.783. [DOI] [PMC free article] [PubMed] [Google Scholar]